Abstract: The present invention relates to friction reducers and to well treatment fluids. In one embodiment there is provided a friction reducing composition comprising (a) a phosphonium compound and (b) a polymeric friction reducer. In a further embodiment there is provided a well treatment fluid comprising a phosphonium compound.

Abstract: The invention relates to the technical field of supporting patients in the repeated taking of drugs within the context of a therapeutic treatment. The invention relates to a method, to a system, and to a computer program product that monitor the taking of drugs by a patient and inform the patient or a doctor or another person if a drug portion should not be taken in order to thus optimize the effectiveness of the treatment or reduce risks.

Abstract: A method treats an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method includes adding treatment agents to an aqueous system wherein said treatment agents include (a) a phosphonium compound; and (b) a compound having formula: M(XO2)n wherein: M is a Group I or Group II metal; X is a halogen; and n is 1 or 2.

Abstract: In one embodiment, a method of treating an aqueous system inhibits growth of one or more micro-organisms therein and/or reduces the number of live micro-organisms therein. The method includes adding treatment agents to an aqueous system wherein said treatment agents include a phosphonium compound and a hypohalite compound. In one embodiment, the phosphonium compound includes tri n-butyl n-tetradecyl phosphonium chloride (TTPC) and the hypohalite compound includes sodium hypochlorite.

Abstract: The present invention relates to the field of accompanying patients and alleviating the symptoms of a disease, particularly in patients suffering from cardiac insufficiency. The invention relates to a method and a system for monitoring the state of health of a large number of patients.

Abstract: The present invention relates to the treatment of cardiac insufficiency. A sensor for measuring the tissue fluid content in the region of the rib cage is implanted in a person suffering from cardiac insufficiency. If the tissue fluid content does not get back to normal within a defined period of time and under treatment with the available standard therapy, treatment with a V1a/V2 vasopessin receptor antagonist is recommended. Dosage of the V1a/V2 vasopressin receptor antagonist and duration of the treatment with the V1a/V2 vasopressin receptor antagonist can be determined on the basis of the acquired sensor data.

Abstract: A method treats an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method includes adding treatment agents to an aqueous system wherein said treatment agents include (a) a phosphonium compound; and (b) a compound having formula: M(XO2)n wherein: M is a Group I or Group II metal; X is a halogen; and n is 1 or 2.

Abstract: The present invention relates to water treatment. In one example, there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method includes adding treatment agents to an aqueous system wherein said treatment agents include: (a) a phosphonium compound; and (b) a compound having formula: M(XO2)n wherein: M is a Group I or Group II metal; X is a halogen; and n is 1 or 2.

Abstract: The invention relates to the technical field of supporting patients in the repeated taking of drugs within the context of a therapeutic treatment. The invention relates to a method, to a system, and to a computer program product that monitor the taking of drugs by a patient and inform the patient or a doctor or another person if a drug portion should not be taken in order to thus optimize the effectiveness of the treatment or reduce risks.

Abstract: The present invention relates to water treatment. In one embodiment there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method comprises adding treatment agents to said aqueous system and wherein said treatment agents comprise: (a) a phosphonium compound; and (b) a halogen oxide compound.

Abstract: The present invention relates to friction reducers and to well treatment fluids. In one embodiment there is provided a friction reducing composition comprising (a) a phosphonium compound and (b) a polymeric friction reducer. In a further embodiment there is provided a well treatment fluid comprising a phosphonium compound.

Abstract: The present invention relates to friction reducers and to well treatment fluids. In one embodiment there is provided a friction reducing composition comprising (a) a phosphonium compound and (b) a polymeric friction reducer. In a further embodiment there is provided a well treatment fluid comprising a phosphonium compound.

Abstract: The present invention relates to water treatment. In one embodiment there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method comprises adding treatment agents to said aqueous system and wherein said treatment agents comprise: (a) a phosphonium compound; and (b) an oxazolidine compound.

Abstract: The present invention relates to water treatment. In one embodiment there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method comprises adding treatment agents to said aqueous system and wherein said treatment agents comprise: (a) a phosphonium compound; and (b) an nitro compound.

Abstract: The present invention relates to water treatment. In one example, there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method includes adding treatment agents to an aqueous system wherein said treatment agents include: (a) a phosphonium compound; and (b) a compound having formula: M(XO2)n wherein: M is a Group I or Group II metal; X is a halogen; and n is 1 or 2.

Abstract: The present invention relates to water treatment. In one embodiment there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method comprises adding treatment agents to said aqueous system and wherein said treatment agents comprise: (a) a phosphonium compound; and (b) an nitro compound.

Abstract: The present invention relates to water treatment. In one embodiment there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method comprises adding treatment agents to said aqueous system and wherein said treatment agents comprise: (a) a phosphonium compound; and (b) an quaternary ammonium salt (b) having formula: wherein R2 represents a C1-C6 group which is saturated or unsaturated and which is unsubstituted or substituted by a halogen; and X represents either chlorine or bromine.

Abstract: The present invention relates to water treatment. In one embodiment there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method comprises adding treatment agents to said aqueous system and wherein said treatment agents comprise: (a) a phosphonium compound; and (b) an oxazolidine compound.

Abstract: The present invention relates to friction reducers and to well treatment fluids. In one embodiment there is provided a friction reducing composition comprising (a) a phosphonium compound and (b) a polymeric friction reducer. In a further embodiment there is provided a well treatment fluid comprising a phosphonium compound.

Abstract: The present invention relates to water treatment. In one embodiment there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method comprises adding treatment agents to said aqueous system and wherein said treatment agents comprise: (a) a phosphonium compound; and (b) a halogen oxide compound.